695
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Can real-ear insertion gain deviations from generic fitting prescriptions predict self-reported outcomes?

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 433-441 | Received 14 Sep 2021, Accepted 10 Mar 2022, Published online: 07 Apr 2022
 

Abstract

Objective

The aim of this study was to determine whether the differences in insertion gains from the first fit to generic prescriptions of hearing aids can predict the self-reported hearing aid (HA) outcomes for first-time and experienced HA users.

Design

This was a prospective observational study.

Study Sample

The study included 885 first-time and 330 experienced HA users with a valid real-ear measurement on both ears and answers to the abbreviated version of the Speech, Spatial, and Quality of Hearing (SSQ12) and the International Outcome Inventory for Hearing Aids (IOI-HA) questionnaires.

Results

K-means clustering of gain differences between individual real-ear insertion gain to three generic gain prescriptions (NAL-NL2, NAL-RP, and one-third gain rules) was performed. The gain difference at higher frequencies generally differentiated the clusters. The experienced users in the cluster with fittings closest to NAL-NL2 and NAL-RP prescription were found to exhibit a higher IOI-HA Factor 1 score (representing the overall benefit of the hearing aid use). The gain differences to generic prescription did not affect other self-reported outcomes for first-time and experienced HA users.

Conclusion

The experienced HA users with minimal gain deviations from generic prescriptions reported better self-perceived benefits than users with larger deviations. However, this was not apparent in first-time users.

Acknowledgments

The authors acknowledge the effort of Michael Lyhne Gaihede, Dan Dupont Hougaard, Erik Schmidt, Vijay Narne, and Gérard Loquet during the data collection and extraction of Real-Ear Measurements. The authors also thank Brent Edwards, Scott Brewer, and NAL for providing the NAL-NL2 developer kit and Nikolai Bisgaard for facilitation.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by Innovation Fund Denmark [Grand Solutions 5164-00011B] (Better hEAring Rehabilitation project), Oticon, GN Hearing, Widex-Sivantos Audiology, and other partners (Aalborg University, University of Southern Denmark, the Technical University of Denmark, Force, Aalborg, Odense and Copenhagen University Hospitals).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.